Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT)
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Barry, Henry, et al., editors. "Likelihood of Most Adverse Treatment Outcomes Lowest With Active Surveillance of Clinically Localized Prostate CA (ProtecT)." EE+ POEM Archive, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT).
Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT). In: Barry HH, Ebell MHM, Shaughnessy AFA, et al, eds. EE+ POEM Archive. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT). Accessed February 13, 2025.
Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT). (2025). In Barry, H., Ebell, M. H., Shaughnessy, A. F., & Slawson, D. C. (Eds.), EE+ POEM Archive. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT)
Likelihood of Most Adverse Treatment Outcomes Lowest With Active Surveillance of Clinically Localized Prostate CA (ProtecT) [Internet]. In: Barry HH, Ebell MHM, Shaughnessy AFA, Slawson DCD, editors. EE+ POEM Archive. John Wiley & Sons; 2025. [cited 2025 February 13]. Available from: https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT).
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT)
ID - 1314139
ED - Barry,Henry,
ED - Ebell,Mark H,
ED - Shaughnessy,Allen F,
ED - Slawson,David C,
BT - EE+ POEM Archive
UR - https://evidence.unboundmedicine.com/evidence/view/infoPOEMs/1314139/all/Likelihood of most adverse treatment outcomes lowest with active surveillance of clinically localized prostate CA (ProtecT)
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -